Literature DB >> 19209823

Isoform sorting of tropomyosins.

Claire Martin1, Peter Gunning.   

Abstract

Cytoskeletal tropomyosin (Tm) isoforms show extensive intracellular sorting, resulting in spatially distinct actin-filament populations. Sorting of Tm isoforms has been observed in a number of cell types, including fibroblasts, epithelial cells, osteoclasts, neurons and muscle cells. Different Tm isoforms have differential impact on the activity of a number of actin-binding proteins and can therefore differentially regulate actin filament function. Functionally distinct sub-populations of actin filaments can therefore be defined on the basis of the Tm isoforms associated with the filaments. The mechanisms that underlie Tm sorting are not yet well understood, but it is clear that Tm sorting is a very fluid and dynamic process, with changes in sorting occurring throughout development and cell differentiation. For this reason, it is unlikely that Tm localization is determined by an intrinsic sorting signal that directs particular isoforms to a single geographical location. Rather, a molecular sink model where isoforms accumulate in actin-based structures where they have the highest affinity, is most consistent with current data. This model would predict Tm sorting to be influenced by changes to actin filament dynamics and organization and collaboration with other actin-binding proteins.

Mesh:

Substances:

Year:  2008        PMID: 19209823     DOI: 10.1007/978-0-387-85766-4_15

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  13 in total

1.  Tropomyosin isoforms and reagents.

Authors:  Galina Schevzov; Shane P Whittaker; Thomas Fath; Jim Jc Lin; Peter W Gunning
Journal:  Bioarchitecture       Date:  2011-07-01

Review 2.  Vascular smooth muscle phenotypic diversity and function.

Authors:  Steven A Fisher
Journal:  Physiol Genomics       Date:  2010-08-24       Impact factor: 3.107

3.  Tropomyosin variants describe distinct functional subcellular domains in differentiated vascular smooth muscle cells.

Authors:  Cynthia Gallant; Sarah Appel; Philip Graceffa; Paul Leavis; Jim Jung-Ching Lin; Peter W Gunning; Galina Schevzov; Christine Chaponnier; Jon DeGnore; William Lehman; Kathleen G Morgan
Journal:  Am J Physiol Cell Physiol       Date:  2011-02-02       Impact factor: 4.249

4.  Structural analysis of smooth muscle tropomyosin α and β isoforms.

Authors:  Jampani Nageswara Rao; Roland Rivera-Santiago; Xiaochuan Edward Li; William Lehman; Roberto Dominguez
Journal:  J Biol Chem       Date:  2011-11-27       Impact factor: 5.157

Review 5.  New insights into the regulation of the actin cytoskeleton by tropomyosin.

Authors:  C-L Albert Wang; Lynne M Coluccio
Journal:  Int Rev Cell Mol Biol       Date:  2010       Impact factor: 6.813

6.  Tropomyosin and myosin-II cellular levels promote actomyosin ring assembly in fission yeast.

Authors:  Benjamin C Stark; Thomas E Sladewski; Luther W Pollard; Matthew Lord
Journal:  Mol Biol Cell       Date:  2010-01-28       Impact factor: 4.138

7.  Tropomyosin Promotes Lamellipodial Persistence by Collaborating with Arp2/3 at the Leading Edge.

Authors:  Simon Brayford; Nicole S Bryce; Galina Schevzov; Elizabeth M Haynes; James E Bear; Edna C Hardeman; Peter W Gunning
Journal:  Curr Biol       Date:  2016-04-21       Impact factor: 10.834

8.  Stretching actin filaments within cells enhances their affinity for the myosin II motor domain.

Authors:  Taro Q P Uyeda; Yoshiaki Iwadate; Nobuhisa Umeki; Akira Nagasaki; Shigehiko Yumura
Journal:  PLoS One       Date:  2011-10-13       Impact factor: 3.240

9.  TPM3 and TPM4 gene products segregate to the postsynaptic region of central nervous system synapses.

Authors:  Kim Guven; Peter Gunning; Thomas Fath
Journal:  Bioarchitecture       Date:  2011-11-01

10.  Mutations changing tropomodulin affinity for tropomyosin alter neurite formation and extension.

Authors:  Natalia Moroz; Laurent Guillaud; Brinda Desai; Alla S Kostyukova
Journal:  PeerJ       Date:  2013-02-12       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.